Biliary excretion of colchicine.

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Hepatobiliary Transport

Background:

• Colchicine is an established therapeutic agent with known toxicities.
• Understanding drug excretion routes is crucial for optimizing dosing and predicting drug interactions.

Purpose of the Study:

• To investigate the role of biliary excretion in the elimination of colchicine.
• To characterize the species-specific differences in colchicine biliary excretion.
• To determine if colchicine excretion into bile is an active transport process.

Main Methods:

• Intravenous administration of radiolabeled colchicine (3H-colchicine) to rats, hamsters, dogs, and rabbits.
• Collection and analysis of fecal and biliary excretions.
• Measurement of drug and metabolite concentrations in bile, plasma, and liver tissue.
• Calculation of bile/plasma, liver/plasma, and bile/liver concentration gradients.

Main Results:

• Rats excreted 68% of 3H-colchicine in feces within 48 hours, suggesting significant biliary excretion.
• In rats, 50% of a colchicine dose was recovered in bile within 2 hours, containing parent drug and metabolites.
• Colchicine was actively transported into rat bile against a steep concentration gradient (bile/plasma ratio of 800).
• Significant species differences in biliary excretion percentages (16-32%) and parent drug recovery in bile (45-72%) were observed in hamsters, dogs, and rabbits.
• All studied species excreted colchicine into bile against concentration gradients, confirming active transport.

Conclusions:

• Biliary excretion is a major elimination pathway for colchicine, particularly in rats.
• Colchicine undergoes active transport into bile across multiple species.
• Species-specific differences in biliary excretion and metabolism influence colchicine pharmacokinetics.